273 related articles for article (PubMed ID: 15272050)
1. Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo.
Minakuchi Y; Takeshita F; Kosaka N; Sasaki H; Yamamoto Y; Kouno M; Honma K; Nagahara S; Hanai K; Sano A; Kato T; Terada M; Ochiya T
Nucleic Acids Res; 2004 Jul; 32(13):e109. PubMed ID: 15272050
[TBL] [Abstract][Full Text] [Related]
2. Delivery of small interfering RNA with a synthetic collagen poly(Pro-Hyp-Gly) for gene silencing in vitro and in vivo.
Adachi T; Kawakami E; Ishimaru N; Ochiya T; Hayashi Y; Ohuchi H; Tanihara M; Tanaka E; Noji S
Dev Growth Differ; 2010 Oct; 52(8):693-9. PubMed ID: 20874713
[TBL] [Abstract][Full Text] [Related]
3. Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA.
Sabbioni S; Callegari E; Manservigi M; Argnani R; Corallini A; Negrini M; Manservigi R
Gene Ther; 2007 Mar; 14(5):459-64. PubMed ID: 17051250
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA.
Zhang YA; Nemunaitis J; Samuel SK; Chen P; Shen Y; Tong AW
Cancer Res; 2006 Oct; 66(19):9736-43. PubMed ID: 17018633
[TBL] [Abstract][Full Text] [Related]
5. [Experimental study of MAT1 gene silencing mediated by siRNA in pancreatic cancer].
Liu JP; Yuan SZ; Zhang SN
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2719-23. PubMed ID: 18167254
[TBL] [Abstract][Full Text] [Related]
6. Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition.
Yoo JY; Kim JH; Kim J; Huang JH; Zhang SN; Kang YA; Kim H; Yun CO
Gene Ther; 2008 May; 15(9):635-51. PubMed ID: 18273054
[TBL] [Abstract][Full Text] [Related]
7. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.
Yoshizawa T; Hattori Y; Hakoshima M; Koga K; Maitani Y
Eur J Pharm Biopharm; 2008 Nov; 70(3):718-25. PubMed ID: 18647651
[TBL] [Abstract][Full Text] [Related]
8. Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing.
Bartlett DW; Davis ME
Biotechnol Bioeng; 2007 Jul; 97(4):909-21. PubMed ID: 17154307
[TBL] [Abstract][Full Text] [Related]
9. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
Sun Y; Li Z; Li L; Li J; Liu X; Li W
Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery.
Landen CN; Chavez-Reyes A; Bucana C; Schmandt R; Deavers MT; Lopez-Berestein G; Sood AK
Cancer Res; 2005 Aug; 65(15):6910-8. PubMed ID: 16061675
[TBL] [Abstract][Full Text] [Related]
11. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo.
Urban-Klein B; Werth S; Abuharbeid S; Czubayko F; Aigner A
Gene Ther; 2005 Mar; 12(5):461-6. PubMed ID: 15616603
[TBL] [Abstract][Full Text] [Related]
12. A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics.
Takei Y; Kadomatsu K; Yuzawa Y; Matsuo S; Muramatsu T
Cancer Res; 2004 May; 64(10):3365-70. PubMed ID: 15150085
[TBL] [Abstract][Full Text] [Related]
13. A tightly regulated and reversibly inducible siRNA expression system for conditional RNAi-mediated gene silencing in mammalian cells.
Wu RH; Cheng TL; Lo SR; Hsu HC; Hung CF; Teng CF; Wu MP; Tsai WH; Chang WT
J Gene Med; 2007 Jul; 9(7):620-34. PubMed ID: 17486668
[TBL] [Abstract][Full Text] [Related]
14. Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis.
Schiffelers RM; Xu J; Storm G; Woodle MC; Scaria PV
Arthritis Rheum; 2005 Apr; 52(4):1314-8. PubMed ID: 15818667
[TBL] [Abstract][Full Text] [Related]
15. Atelocollagen-mediated local and systemic applications of myostatin-targeting siRNA increase skeletal muscle mass.
Kinouchi N; Ohsawa Y; Ishimaru N; Ohuchi H; Sunada Y; Hayashi Y; Tanimoto Y; Moriyama K; Noji S
Gene Ther; 2008 Aug; 15(15):1126-30. PubMed ID: 18323791
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity and prolonged survival by carbon-nanotube-mediated therapeutic siRNA silencing in a human lung xenograft model.
Podesta JE; Al-Jamal KT; Herrero MA; Tian B; Ali-Boucetta H; Hegde V; Bianco A; Prato M; Kostarelos K
Small; 2009 May; 5(10):1176-85. PubMed ID: 19306454
[TBL] [Abstract][Full Text] [Related]
17. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
Aigner A
J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
[TBL] [Abstract][Full Text] [Related]
18. [Inhibition of HPV16 E6 oncogene in cervical cancer by RNA interference].
Niu XY; Peng ZL; Duan WQ; Wang H; Chen YY; Fan YJ; Cheng YF; Qian XL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):14-8. PubMed ID: 16468632
[TBL] [Abstract][Full Text] [Related]
19. Rational design and in vitro and in vivo delivery of Dicer substrate siRNA.
Amarzguioui M; Lundberg P; Cantin E; Hagstrom J; Behlke MA; Rossi JJ
Nat Protoc; 2006; 1(2):508-17. PubMed ID: 17406276
[TBL] [Abstract][Full Text] [Related]
20. Atelocollagen-mediated systemic administration of myostatin-targeting siRNA improves muscular atrophy in caveolin-3-deficient mice.
Kawakami E; Kinouchi N; Adachi T; Ohsawa Y; Ishimaru N; Ohuchi H; Sunada Y; Hayashi Y; Tanaka E; Noji S
Dev Growth Differ; 2011 Jan; 53(1):48-54. PubMed ID: 21261610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
